Target intelligence / Profile preview

U2 small nuclear RNA 32, pseudogene (RNU2-32P)

Target
RNU2-32P
Molecular classification
Other (non-coding RNA pseudogene)
01

Overview

U2 small nuclear RNA 32, pseudogene (RNU2-32P) is a pseudogene in the human genome that resembles the gene encoding U2 small nuclear RNA (snRNA), a core component of the spliceosome involved in pre-mRNA splicing[2][1]. Pseudogenes like RNU2-32P are generally considered non-functional: they typically do not produce a functional RNA or protein product and are not active in key biological processes[3]. The canonical, functional U2 small nuclear RNA genes (such as RNU2-1 and RNU2-2) are critical for proper mRNA processing and genetic stability[2][3][1]. However, RNU2-32P itself is classified as a **pseudogene**, meaning it likely does **not** have a role as a receptor, enzyme, transporter, or other therapeutic target, and it does **not** produce a functional U2 snRNA molecule. There is currently no evidence linking RNU2-32P to particular diseases, drug interactions, or use as a biomarker. **Key notes:** - The functional U2 snRNA genes are important in splicing, but pseudogene copies such as RNU2-32P do not contribute to this function[3][2]. - Some U2 snRNA pseudogenes have been annotated due to sequence similarity to active snRNA genes, but most have no known expression or function[3]. - Other pseudogenes labeled similarly (e.g., RNU2-2P, now re-annotated as functional RNU2-2) have been shown, only after detailed analysis, to be functional genes; however, RNU2-32P lacks such evidence[3]. - RNU2-32P is not considered a therapeutic target.

Other names
RNU2-32PRNA, U2 small nuclear 32, pseudogene
02

Biological functions

Other (no known functional RNA produced; see notes below)
03

Disease associations

Other (no known direct involvement)

Beyond the preview

Go deeper on U2 small nuclear RNA 32, pseudogene (RNU2-32P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on U2 small nuclear RNA 32, pseudogene (RNU2-32P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call